Anti-CD33 antibody [EPR4423]
- 20ul selling size
- RabMAb
- KO Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Knockout Tested Rabbit Recombinant Monoclonal CD33 antibody. Suitable for IP, Flow Cyt, WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
CD33, SIGLEC3, Myeloid cell surface antigen CD33, Sialic acid-binding Ig-like lectin 3, gp67, Siglec-3
- Flow Cyt
Lab
Flow Cytometry - Anti-CD33 antibody [EPR4423] (AB134115)
Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte, Left) / THP1 (Human monocytic leukemia monocyte, Right) labeling CD33 with ab134115 at 1/500 dilution (red). Goat anti rabbit IgG (Alexa Fluor® 647, ab150079) at 1/2000 dilution was used as the secondary antibody. Rabbit monoclonal IgG (ab172730) was used as isotype control (Black). Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue).
Negative control : Jurkat.
Gated on viable cells.
- IP
Unknown
Immunoprecipitation - Anti-CD33 antibody [EPR4423] (AB134115)
ab134115 (purified) at 1/60 immunoprecipitating CD33 in 10 μg THP-1 (Lanes 1 and 2, observed at 67-75 kDa). Lane 3 - PBS. For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution. Blocking buffer and concentration : 5% NFDM/TBST Dilution buffer and concentration : 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-CD33 antibody [EPR4423] (ab134115)
Predicted band size: 40 kDa
false
- WB
Lab
Western blot - Anti-CD33 antibody [EPR4423] (AB134115)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-CD33 antibody [EPR4423] (ab134115) at 1/5000 dilution
Lane 1:
THP-1 cell lysate at 10 µg
Lane 2:
U937 cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit IgG (H+L) at 1/20000 dilution
Predicted band size: 40 kDa
Observed band size: 67 kDa,75 kDa
false
- WB
Supplier Data
Western blot - Anti-CD33 antibody [EPR4423] (AB134115)
False colour image of Western blot : Anti-CD33 antibody [EPR4423] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab134115 was shown to bind specifically to CD33. A band was observed at 60-80 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CD33 knockout cell line ab273831 (knockout cell lysate ab273785). To generate this image, wild-type and CD33 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CD33 antibody [EPR4423] (ab134115) at 1/1000 dilution
Lane 1:
Wild-type THP-1 cell lysate at 10 µg
Lane 2:
Western blot - Human CD33 knockout THP-1 cell lysate (ab273785) at 10 µg
Lane 3:
HL-60 cell lysate at 10 µg
Lane 4:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 40 kDa
Observed band size: 60-80 kDa
false
- WB
Unknown
Western blot - Anti-CD33 antibody [EPR4423] (AB134115)
All lanes:
Western blot - Anti-CD33 antibody [EPR4423] (ab134115) at 1/1000 dilution
Lane 1:
THP1 cell lysate at 10 µg
Lane 2:
U937 cell lysate at 10 µg
Lane 3:
HL60 cell lysate at 10 µg
Lane 4:
HepG2 cell lysate at 10 µg
Lane 5:
HeLa cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution
Predicted band size: 40 kDa
Observed band size: 67-75 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CD33 antibody [EPR4423] (AB134115)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (2)
-
Anti-CD33 antibody [EPR4423] - BSA and Azide free
-
Anti-CD33 antibody [EPR4423] - Low endotoxin, Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 30:456 PubMed40762017
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 28:468 PubMed39119236
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular psychiatry 29:2084-2094 PubMed38383769
2024
Applications
Unspecified application
Species
Unspecified reactive species
EBioMedicine 95:104732 PubMed37506557
2023
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 33:10425-10442 PubMed31219699
2019
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 82:552-560 PubMed26369878
2015
Applications
WB
Species
Human
Neurobiology of aging 36:571-82 PubMed25448602
2014
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com